Description
Fortum Powder for Solution for Injections/Infusions 2 g
Composition:
Each vial contains 2 g of ceftazidime (as pentahydrate).
Mechanism of Action:
Ceftazidime exerts its bactericidal effect by inhibiting bacterial cell wall synthesis. It penetrates the bacterial cell wall and binds to penicillin-binding proteins, leading to the inhibition of peptidoglycan cross-linking and eventual cell lysis. This mechanism of action makes ceftazidime effective against a wide range of Gram-negative bacteria.
Pharmacological Properties:
Fortum (ceftazidime) is a third-generation cephalosporin antibiotic with broad-spectrum activity against many Gram-negative bacteria.
Indications for Use:
- Respiratory tract infections
- Skin and soft tissue infections
- Urinary tract infections
- Septicemia
Contraindications:
Do not use Fortum if there is a history of hypersensitivity to cephalosporins. Caution is advised in patients with a history of gastrointestinal disease, particularly colitis.
Side Effects:
Common side effects may include gastrointestinal disturbances, hypersensitivity reactions, and superinfection. Consult a healthcare provider for more information.
Usage Instructions:
Fortum is for intravenous or intramuscular use only. It should be reconstituted with the appropriate diluent as directed before administration.
Benefits Compared to Analogues:
Fortum has demonstrated similar or superior effectiveness compared to other antibiotics in its class, as shown in clinical trials.
Suitable Patient Groups:
Fortum is suitable for adults with bacterial infections. Dosage adjustments may be necessary for children and elderly patients based on individual factors.
Storage and Shelf Life:
Store Fortum according to the instructions provided on the packaging. Check the expiration date before use and do not use expired products.
Packaging Description:
Fortum is available in vials containing 2 g of ceftazidime (as pentahydrate) for solution for injections/infusions.
Clinical Evidence and Proven Effectiveness:
Fortum has been shown to be effective in treating serious infections, including those caused by Pseudomonas aeruginosa. Research published in the Journal of Antimicrobial Chemotherapy demonstrated the effectiveness of ceftazidime in the treatment of nosocomial pneumonia.
